Preservé® is...
An advanced less invasive* breast enhancement technique made possible by patented technologies
and designed to preserve the patient's native breast tissue functionality, including nipple sensation and chest muscles.1,2
*Compared to traditional breast augmentation.
Preservé® is for Women Desiring:
-
Primary breast augmentation
-
Primary breast augmentation mastopexy
-
Hybrid breast augmentation techniques
Preservé® is for women seeking primary breast augmentation, mastopexy augmentation or reshaping
through hybrid breast augmentation techniques. They prioritize natural looking, harmonious aesthetics while maintaining
the breast's structure, function, value safety, minimally invasive procedures, longevity, and desire
personalized solutions tailored to their anatomy, lifestyle, and aspirations.³
The Art of Preservé®
The Preservé® procedure is designed to be performed through a less invasive* technique
with minimal anesthesia13 allowing for a fast post-procedure recovery.1,2*
*As compared to traditional breast augmentation
Step 1
Infiltrate the area with tumescent solution to access the Tissue Preservation space. Allow the solution to take effect for 10 min before proceeding.
Step 2
Create approximatively a 3 cm incision in the inframmary fold.
Step 3
Using the Motiva® Channel Separator to create a tunnel8 from the IMF (Inframammary fold) to the opposing border of the desired breast pocket9. The tip allows for gentle soft tissue separation, designed to reduce trauma and preserve the breast's natural tissue support9.
Step 4
The Motiva® Inflatable Balloon is then used to create the breast pocket by gradually inflating and gently expanding the breast tissues in a controlled manner before deflating and removal.1,2
Step 5
The implant is then inserted via a no touch technique using an insertion sleeve.
Preserving Your Natural Breast Tissue
Watch the video below.
-
Preservé® Breast Anatomy
Preservé® is an innovative, less invasive* breast augmentation surgery, designed to preserve the patient’s native breast tissue functionality, including nipple sensation and chest muscles.1,2
-
Preservé® Breast Stability
Preservé® is designed to avoid disruption to the pectoralis major muscle and to minimize the damage to the natural breast structures.1,2 The Preservé® technique elongates the native tissue to create a nest for the breast implant support, as evidenced by a clinical study which reported a 0% rate of inferior malposition at three years.1,2
-
Preservé® Peace of Mind
Preservé® offers peace of mind to you and your patients through a less invasive breast augmentation technique* designed to be less invasive and reduce tissue damage.1,2 When choosing the Motiva SmoothSilk Ergonomix® implant with Preservé®, patients can also benefit from low inflammation7 and low complications.14 -
Preservé® Breast Softness
The Motiva SmoothSilk Ergonomix® implant, a perfect choice for the Preservé® procedure, offers benefits to patients including smaller incisions,12 soft breast7 and low device related complications,14 all while conserving their native breast tissue and chest muscles, for a quick recovery.1,2*
*As compared to traditional breast augmentation
A Perfect Choice,
Motiva SmoothSilk Ergonomix®
Motiva SmoothSilk Ergonomix® implants are unique to the implant market, as they can adapt shape as your body changes positions, showcasing a round shape when lying down and a teardrop shape when standing up. This allows the implant to realistically mimic the look, feel and movement of a natural breast.4-6
This breakthrough implant is designed to be inserted through a small incision,12 making it a perfect choice for Preservé® procedures.
What women are saying
“I would always look at myself and feel like my breasts didn’t quite match my body. They feel so natural, they look natural, and honestly, I don’t even remember how they looked before. And the recovery, for me, was the best part because I honestly never felt like I had surgery. You might hesitate at first out of fear, but once you’ve done it, you’re so happy, and you think, “Why didn’t I do this sooner? ”
Fabiana
Preservé® Patient
Ergonomix® Demi 180cc
Testimonial given reflect the real-life experience of patients who have undergone implantation of Motiva Implants* with the Preservé® procedure. Results may vary and we do not claim, nor should it be assumed, that any individual experience recounted is typical or representative of what any other individual may experience. These testimonials are freely and voluntarily provided, but patient may have received benefits such as free product in exchange for their participation in Establishment Labs training programs. Please speak with your doctor or local healthcare provider to determine if the Preservé® procedure and Motiva Implants® are right for you.
Preservé® Before & Afters
Explore patient results by projection.
Contact a Motiva® Representative to learn how you can offer Preservé® in your practice.
References
1. Chacon-Quiros M, Sforza M, Solis-Chaves P, et al. The 3-year results of a 100-patient prospective study of safety and effectiveness of Mia Femtech. Aesthet Surg J. 2025;sjaf196. doi:10.1093/asj/sjaf196
2. Establishment Labs. CLIN-001037: Motiva® Breast Tissue Preservation™ Techniques. Data on file.
3. Establishment Labs. Kantar Study. Among 4,962 women aged 20 to 60 years old. France, Germany, Italy, Spain, Sweden, Switzerland and the UK. Mid-High income. Data on file.
4. Aitzetmuller-Kleitz ML, Yang S, Wiebinghaus P, Wellenbrock S, Ozturk M, Kuckelhaus M et al. Complication rates after breast surgery with the Motiva Smooth SilkSurface silicone gel implants - A systematic review and meta-analysis. Clin. Med. 2023, 12,1881. doi: 10.3390/jcm12051881
5. Establishment Labs, TR-001038: Rheological analysis of silicone filling gels of Motiva Implants® and other brands’ silicone filling gels using the BTC-2000. Data on File.
6. Establishment Labs, DDD-002: Device Description Document for Sterile Silicone Breast Implants Motiva Implants® Ergonomix® Round SmoothSilk®/SilkSurface®. Data on File.
7. Doloff JC, Veiseh O, de Mezerville R, et al. The surface topography of silicone breast implants mediates the foreign body response in mice, rabbits, and humans. Nat Biomed Eng. 2021. doi:10.1038/s41551-021-00739-4
8. Establishment Labs, DOC-001075: Channel Separator Instructions for Use. Internal Data on File.
9. Establishment Labs. CLIN-001033: Clinical assessment of the Motiva® Channel Separator intended use update. Data on file.
10. Establishment Labs. TD-001004: Motiva® Inflatable Balloon Technical Document. Data on file.
11. Establishment Labs. DOC-0010073: Motiva® Inflatable Balloon Directions for Use. Data on file.
12. Zeplin PH. Narbensparende Brustvergrößerung: Erfahrungen mit über 500 Implantaten. Handchirurgie · Mikrochirurgie · Plastische Chirurgie. 2021;53(02):144-148. doi:10.1055/a-1307-3917
13. Tebbets J. Redifining the patient and surgeon experience. 2010. Mosby, Elsevier. ISBN: 978-0-323-04112-6
14. Glicksman C, Wolfe A, McGuire P. The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: 5-Year Clinical Data. Aesthet Surg J. 2025 Nov 20:sjaf245. doi: 10.1093/asj/sjaf245. Epub ahead of print. PMID: 41266083.
Preservé® clinical outcome data is currently based on the use of the Motiva Channel Seperator, the Motiva Inflatable Balloon and the Ergonomix2 implant in minimally invasive procedures in Motiva’s OUS markets. While the Ergonomix2 implant is not approved in the U.S., the Motiva Inflatable Balloon and the Motiva Channel Seperator used for the Breast Tissue Preservation System are registered with the FDA and may be used with FDA approved implants.
The sale and distribution of this device are restricted to users and/or user facilities that provide information to patients about the risks and benefits of this device in the form and manner specified in the approved labeling provided by Motiva USA.
IMPORTANT SAFETY INFORMATION
The Motiva SmoothSilk® Round and SmoothSilk Ergonomix® Silicone Gel Breast Implants are indicated for breast augmentation for women of at least 22 years old. Breast augmentation includes primary breast surgery to increase the breast size, as well as revision surgery to correct or improve the result of an original primary breast augmentation surgery (i.e., revision-augmentation). Breast Implant surgery is contraindicated in women with active infection anywhere in their bodies, with existing cancer or pre-cancer of their breast who have not received sufficient treatment for those conditions, or who are currently pregnant or nursing. Adequate studies have not been performed to confirm the safety of breast implant surgery in women with these conditions or under these circumstances; therefore, if you have any of the conditions or circumstances listed above, breast augmentation surgery with implants should not be performed at this time. Failure to take into consideration these contraindications may increase the risks involved with breast implant surgery and have the potential to cause harm. Patients should be advised that key complications have historically been associated with silicone gel breast surgery and implantation of silicone gel breast implants including, but not limited to, capsular contracture, implant removal, reoperation, infection, and rupture. Further, breast implants are not lifetime devices and patients should visit their healthcare professional, as recommended. For more detailed information about the benefits and risks of Motiva SmoothSilk® Round and SmoothSilk Ergonomix® Silicone Gel Breast Implants, please visit: www.motivausa.com or call Motiva at 1-800-924-5072.
Motiva®, Establishment Labs®, Aesthetic BreastRecon®, and Ergonomix® are trademarks of Establishment Labs Holdings® Inc.